US Patent Issued to AGENEBIO on Oct. 27 for "Polymorphs of a GABA a Alpha5 agonist and methods of using in the treatment of cognitive impairment" (New York, Indiana, Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,283, issued on Oct. 27, was assigned to AGENEBIO INC. (Baltimore).

"Polymorphs of a GABA a Alpha5 agonist and methods of using in the treatment of cognitive impairment" was invented by Deepa Gandla (Albany, N.Y.), Brian Gregg (Albany, N.Y.), Vishnumurthy Hegde (Glen Mills, Pa.), Stephan D. Parent (West Lafayette, Ind.) and Travis Lee Houston (Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Crystalline forms of a GABAA Alpha5 agonist, pharmaceutical compositions and combinations comprising those crystalline forms, their use in methods of treating cognitive impairment associated with central nervous system (CNS) disorders, cognitive imp...